Jingzhou Wang

Jingzhou Wang is an Associate Principal Scientist at Merck & Co., where he specializes in computational structural biology and its application to drug discovery. His work focuses on integrating computational and experimental (“wet/dry lab”) approaches to advance the design and optimization of complex therapeutics, including ADCs. Jingzhou has contributed to innovations in structural and molecular engineering to improve targeting, stability, and efficacy in next generation bioconjugates. With a strong background in computational biology and protein design, he brings a multidisciplinary perspective to accelerating the development of novel medicines.